Mackay Shields LLC Innoviva, Inc. Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $745,395 - $908,796	-65,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $306,362 - $356,499	-27,700 Reduced 29.85%	65,100 $778,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $906,876 - $1.21 Million	-97,200 Reduced 51.16%	92,800 $1.15 Million
Q3 2020 Nov 04, 2020	SELL	$10.33 - $14.49 $243,788 - $341,964	-23,600 Reduced 11.05%	190,000 $1.99 Million
Q2 2020 Jul 31, 2020	SELL	$11.49 - $15.26 $103,410 - $137,340	-9,000 Reduced 4.04%	213,600 $2.99 Million
Q1 2020 May 08, 2020	SELL	$8.11 - $15.23 $153,279 - $287,847	-18,900 Reduced 7.83%	222,600 $2.62 Million
Q4 2019 Feb 11, 2020	BUY	$10.28 - $14.38 $2.48 Million - $3.47 Million	241,500 New	241,500 $3.42 Million

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.